Lenalidomide and Dexamethasone Asymptomatic multiple Myeloma with high Risk of Disease Progression

被引：0
|
作者：
Ahlborn, M. [1 ]
机构：
[1] Stadt Klinikum Braunschweig, Med Klin 3, D-38114 Braunschweig, Germany
来源：
ONKOLOGE | 2013年 / 19卷 / 12期
关键词：
D O I：
10.1007/s00761-013-2591-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1076 / 1077
页数：2
相关论文
共 50 条
  • [1] RISK OF DISEASE PROGRESSION IN ASYMPTOMATIC MULTIPLE-MYELOMA
    DIMOPOULOS, MA
    MOULOPOULOS, A
    SMITH, T
    DELASALLE, KB
    ALEXANIAN, R
    AMERICAN JOURNAL OF MEDICINE, 1993, 94 (01): : 57 - 61
  • [2] Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
    Mateos, Maria-Victoria
    Hernandez, Miguel-Teodoro
    Giraldo, Pilar
    de la Rubia, Javier
    de Arriba, Felipe
    Lopez Corral, Lucia
    Rosinol, Laura
    Paiva, Bruno
    Palomera, Luis
    Bargay, Joan
    Oriol, Albert
    Prosper, Felipe
    Lopez, Javier
    Olavarria, Eduardo
    Quintana, Nuria
    Garcia, Jose-Luis
    Blade, Joan
    Lahuerta, Juan-Jose
    San Miguel, Jesus-F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05): : 438 - 447
  • [3] Addition Of Clarithromycin To Lenalidomide and Dexamethasone (BiRd) Is Effective In Multiple Myeloma After Progression On Lenalidomide and Dexamethasone
    Ghosh, Nilanjan
    Tucker, Noah
    Zahurak, Marianna
    Wozney, Jocelyn L.
    Borrello, Ivan M.
    Huff, Carol Ann
    BLOOD, 2013, 122 (21)
  • [4] Ixazomib, Lenalidomide and Dexamethasone: a new combination in cytogenetic high risk multiple myeloma
    Chiche, Edmond
    Leleu, Xavier
    Richez, Valentine
    HEMATOLOGIE, 2018, 24 (01): : 18 - 19
  • [5] Lenalidomide plus dexamethasone in multiple myeloma
    Das, Manjulika
    LANCET ONCOLOGY, 2018, 19 (01): : E12 - E12
  • [6] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Dimopoulos, M. A.
    Oriol, A.
    Nahi, H.
    San-Miguel, J.
    Bahlis, N. J.
    Usmani, S. Z.
    Rabin, N.
    Orlowski, R. Z.
    Komarnicki, M.
    Suzuki, K.
    Plesner, T.
    Yoon, S. -S.
    Ben Yehuda, D.
    Richardson, P. G.
    Goldschmidt, H.
    Reece, D.
    Lisby, S.
    Khokhar, N. Z.
    O'Rourke, L.
    Chiu, C.
    Qin, X.
    Guckert, M.
    Ahmadi, T.
    Moreau, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14): : 1319 - 1331
  • [7] Risk factors for neutropenia with lenalidomide plus dexamethasone therapy for multiple myeloma
    Mitani, Y.
    Usami, E.
    Kimura, M.
    Nakao, T.
    Okada, K.
    Matsuoka, T.
    Kokuryou, T.
    Yoshimura, T.
    Yamakawa, M.
    PHARMAZIE, 2016, 71 (06): : 349 - 351
  • [8] Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma
    Biran, Noa
    Gourna Paleoudis, Elli
    Feinman, Rena
    Vesole, David H.
    Zenreich, Joshua
    Wang, Shuqi
    Ahn, Jaeil
    Bansal, Meena
    Rowley, Scott
    Donato, Michele
    Pecora, Andrew L.
    Richter, Joshua
    Anand, Palka
    McBride, Laura
    Ivanovski, Kristin
    Korngold, Robert
    Siegel, David S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (11) : E430 - E433
  • [9] Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
    Leypoldt, Lisa B.
    Tichy, Diana
    Besemer, Britta
    Haenel, Mathias
    Raab, Marc S.
    Mann, Christoph
    Munder, Markus
    Reinhardt, Hans Christian
    Nogai, Axel
    Goerner, Martin
    Ko, Yon-Dschun
    de Wit, Maike
    Salwender, Hans
    Scheid, Christof
    Graeven, Ullrich
    Peceny, Rudolf
    Staib, Peter
    Dieing, Annette
    Einsele, Hermann
    Jauch, Anna
    Hundemer, Michael
    Zago, Manola
    Pozek, Ema
    Benner, Axel
    Bokemeyer, Carsten
    Goldschmidt, Hartmut
    Weisel, Katja C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 26 - +
  • [10] Carfilzomib, Lenalidomide and Dexamethasone (KRd) Vs Bortezomib, Lenalidomide, and Dexamethasone (VRd) As Induction Therapy in Newly Diagnosed High-Risk Multiple Myeloma
    Tan, Carlyn
    Nemirovsky, David
    Derkach, Andriy
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi A.
    Patel, Dhwani
    Maclachlan, Kylee H.
    Lahoud, Oscar B.
    Shah, Gunjan L.
    Scordo, Michael
    Chung, David J.
    Landau, Heather
    Giralt, Sergio A.
    Lesokhin, Alexander M.
    Korde, Neha
    Usmani, Saad
    BLOOD, 2022, 140 : 1817 - 1819
12345